HK1014945A1 - 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them - Google Patents

2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HK1014945A1
HK1014945A1 HK99100037A HK99100037A HK1014945A1 HK 1014945 A1 HK1014945 A1 HK 1014945A1 HK 99100037 A HK99100037 A HK 99100037A HK 99100037 A HK99100037 A HK 99100037A HK 1014945 A1 HK1014945 A1 HK 1014945A1
Authority
HK
Hong Kong
Prior art keywords
alkyl
preparation
pharmaceutical compositions
compositions containing
heterocyclic rings
Prior art date
Application number
HK99100037A
Other languages
English (en)
Inventor
Jean-Louis Peglion
Bertrand Goument
Mark Millan
Alain Gobert
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of HK1014945A1 publication Critical patent/HK1014945A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
HK99100037A 1997-02-27 1999-01-07 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them HK1014945A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9702360A FR2760014B1 (fr) 1997-02-27 1997-02-27 Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
HK1014945A1 true HK1014945A1 (en) 1999-10-08

Family

ID=9504253

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99100037A HK1014945A1 (en) 1997-02-27 1999-01-07 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them

Country Status (19)

Country Link
US (1) US5968954A (de)
EP (1) EP0861837B1 (de)
JP (1) JPH10237071A (de)
CN (1) CN1090627C (de)
AT (1) ATE265451T1 (de)
AU (1) AU725756B2 (de)
BR (1) BR9800763A (de)
CA (1) CA2231025C (de)
DE (1) DE69823411T2 (de)
DK (1) DK0861837T3 (de)
ES (1) ES2219853T3 (de)
FR (1) FR2760014B1 (de)
HK (1) HK1014945A1 (de)
HU (1) HU224312B1 (de)
NO (1) NO314307B1 (de)
NZ (1) NZ329853A (de)
PL (1) PL190240B1 (de)
PT (1) PT861837E (de)
ZA (1) ZA981680B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR022230A1 (es) * 1999-01-12 2002-09-04 Abbott Gmbh & Co Kg Compuestos de triazol, composicion farmaceutica que los comprende y uso de los mismos para preparar dicha composicion
SE0103650D0 (sv) * 2001-11-01 2001-11-01 Astrazeneca Ab Therapeutic heterocyclic compounds
IL156595A0 (en) * 2001-01-16 2004-01-04 Astrazeneca Ab Therapeutic heterocyclic compounds
JP5080716B2 (ja) 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
JP2005343790A (ja) * 2002-05-31 2005-12-15 Ajinomoto Co Inc カルシウムチャネル拮抗薬を含有する医薬組成物
US20050165025A1 (en) * 2004-01-22 2005-07-28 Recordati Ireland Ltd. Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists
JPWO2006062063A1 (ja) * 2004-12-08 2008-06-12 アステラス製薬株式会社 ピペリジン誘導体及びその製造法
UY29892A1 (es) * 2005-11-04 2007-06-29 Astrazeneca Ab Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones
WO2020183011A1 (en) 2019-03-14 2020-09-17 Institut Curie Htr1d inhibitors and uses thereof in the treatment of cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9318431D0 (en) * 1993-09-06 1993-10-20 Boots Co Plc Therapeutic agents
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
CN1090627C (zh) 2002-09-11
AU5635998A (en) 1998-09-03
CA2231025A1 (fr) 1998-08-27
PL324982A1 (en) 1998-08-31
HU224312B1 (hu) 2005-07-28
ES2219853T3 (es) 2004-12-01
NO314307B1 (no) 2003-03-03
PL190240B1 (pl) 2005-11-30
US5968954A (en) 1999-10-19
NZ329853A (en) 1999-01-28
JPH10237071A (ja) 1998-09-08
NO980803D0 (no) 1998-02-26
DE69823411D1 (de) 2004-06-03
EP0861837B1 (de) 2004-04-28
BR9800763A (pt) 1999-12-07
NO980803L (no) 1998-08-28
CN1194983A (zh) 1998-10-07
HUP9800422A1 (hu) 1999-12-28
DE69823411T2 (de) 2005-02-17
EP0861837A1 (de) 1998-09-02
ZA981680B (en) 1998-09-04
DK0861837T3 (da) 2004-08-16
CA2231025C (fr) 2003-09-16
AU725756B2 (en) 2000-10-19
HU9800422D0 (en) 1998-04-28
FR2760014A1 (fr) 1998-08-28
FR2760014B1 (fr) 1999-04-09
ATE265451T1 (de) 2004-05-15
PT861837E (pt) 2004-07-30

Similar Documents

Publication Publication Date Title
FR2654104B1 (fr) Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
ZA982607B (en) N-arylpiperidine compounds a process for their preparation and pharmaceutical compositions containing them
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ES2091834T3 (es) Compuestos aromaticos.
EP1108428A3 (de) Zusammensetzungen mit Phenylacetat und dessen Derivaten und deren Verwendung zur Behandlung von viralen Erkrankungen
FI915970A0 (fi) Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper.
HK1014945A1 (en) 2-aminoindan compounds, a process for their preparation and pharmaceutical compositions containing them
CA2251003A1 (fr) Nouveaux composes derives de n-aryl 2-hydroxy alkylamides
NO975121L (no) Nye heterocykliske aminometylforbindelser, fremgangsmÕte ved fremstilling av dem og farmas÷ytiske sammensetninger som inneholder dem
ZA964842B (en) Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them
BR9305752A (pt) Composto composiçao farmaceutica e processo para a preparaçao de um composto de derivados alquila da trazodona
NO981566L (no) Nye aminoforbindelser av 6,7,8,9-tetrahydro-cyklopenta[a]naftalen og av 2,3-dihydro-cyklopenta[e]inden, fremgangsmÕte ved fremstilling av dem og farmas°ytiske sammensetninger som inneholder dem
SE9402596D0 (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa
HUP0303691A2 (hu) Uretánszármazékok, eljárás az előállításukra és alkalmazásuk gyógyszerkészítmények előállítására
HUP9800687A1 (hu) N-aril-piperidin-származékok, eljárás előállításukra, és e vegyületeket tartalmazó gyógyszerkészítmények
MX9601953A (es) Nuevo compesto derivados de 5h-tiazolo [3,2-a] pirimidin-5-ona.
MX9801963A (es) Derivados de benzotiazolona.

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080226